Skip to main content
. 2021 Apr 1;14(2):169–177. doi: 10.1159/000514096

Table 1.

Selected characteristics of the study population (n = 576)

Age, years 8.1±0.5
HTN in parents
 No 434 (79.5)
 Yes 112 (20.5)
Ophthalmic diseases in parents
 No 272 (49.8)
 Yes 274 (50.2)
Parents' BMI
 Low/normal weight 135 (26.1)
 Overweight 269 (51.9)
 Obese 114 (22)
Chronic diseases in childa
 No 464 (82.6)
 Yes 98 (17.4)
Ophthalmic diseases in childa
 No 242 (43.9)
 Yes, already known 242 (43.9)
 Yes, not already known 67 (12.2)
Ophthalmic surgery in childa
 No 557 (99.1)
 Yes 5 (0.9)
Steroid therapy in the last year
 No 301 (53.6)
 Yes 261 (46.4)
Route of administrationb
 Oral 207 (79.3)
 Local (cutaneous, conjunctival, aerosol) 88 (33.7)
 Intravenous injection 5 (1.9)
 Intramuscolar injection 1 (0.4)
SBP, mm Hga 93.7±7.2
 <90th percentile − normal BP 542 (97.5)
 90–94th percentile − elevated BP 5 (0.9)
 ≥95th percentile − HTN 9 (1.6)
DBP, mm Hga 46.4±9.7
 <90th percentile − normal BP 540 (97.1)
 90–94th percentile − elevated BP 2 (0.4)
 ≥95th percentile − HTN 14 (2.5)
BPa
 <90th percentile − normal BP 536 (96.4)
 90–94th percentile − elevated BP 5 (0.9)
 ≥95th percentile − HTN 15 (2.7)
BMIa 18.7±3.7
 <85th percentile − low/normal weight 320 (57.6)
 85–94th percentile − overweight 167(30)
 ≥95th percentile − obese 69 (12.4)
Ocular HTNa
 No 507 (92)
 Yes 44 (8)

Data are presented as the mean ± SD or n (%).

a

The numbers that do not add to 576 are due to missing data for the variable.

b

Percentages do not add up to 100 due to multiple responses.